Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation.

BACKGROUND A kidney transplant recipient inadvertently contracted donor-origin melanoma, which was found to be very advanced at presentation. Withdrawal of immunosuppression failed to induce rejection, and interferon-alpha was required. When florid allograft rejection was in progress, the allograft was removed, before it was recognized that the transplanted melanoma was not being simultaneously rejected. METHODS Subsequent immunotherapy was required, which largely recapitulated treatment of recognized value in autologous melanoma and included interferon-alpha, use of cultured melanoma cells as tumor vaccine, pooled allogeneic cell vaccination, and adoptive immunotherapy using lymphokine-activated killer cells. RESULTS Prolonged immunotherapy eradicated the widespread malignancy, and the patient went on to a successful second renal transplant, with follow-up of over 24 months. CONCLUSIONS This unique case demonstrates the successful cure of advanced transplanted melanoma through the use of immunotherapy, which did not require sophisticated tumor vaccine technology, and successful retransplantation.

[1]  P. Hersey,et al.  Remission of transplanted melanoma--clinical course and tumour cell characterisation. , 1997, Clinical transplantation.

[2]  K. Kishi,et al.  The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon. , 1997, Journal of experimental & clinical cancer research : CR.

[3]  N. Mcfarland,et al.  Control of Islet Intercellular Adhesion Molecule-1 Expression by Interferon-α and Hypoxia , 1996, Diabetes.

[4]  I. Penn Malignant melanoma in organ allograft recipients. , 1996, Transplantation.

[5]  John P. Johnson,et al.  INTERFERON-α-INDUCED ACUTE RENAL ALLOGRAFT REJECTION , 1995 .

[6]  C. Scheibenbogen,et al.  Detection of Residual Tumor Cells in Patients with Malignant Melanoma Responding to Immunotherapy , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[7]  I. Penn Malignancy in transplanted organs , 1993, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  R. Horvat,et al.  Identification of donor melanoma in a renal transplant recipient. , 1992, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[9]  J. Kirkwood,et al.  Role of Interferons in the Thearpy of Melanoma , 1990 .

[10]  H. Koeppen,et al.  Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen , 1990, The Journal of experimental medicine.

[11]  F. Sanfilippo The transmission of disease to allograft recipients via donor organs. , 1989, Current opinion in immunology.

[12]  I. Fidler,et al.  Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines. , 1987, Cancer research.

[13]  M. Suranyi,et al.  Target susceptibility in cell-mediated lympholysis assays correlates with major histocompatibility complex surface antigen expression. , 1987, Transplantation proceedings.

[14]  G. Duggin,et al.  EXPRESSION OF HLA ANTIGENS ON RENAL TUBULAR CELLS IN CULTURE: I. EVIDENCE THAT MIXED LYMPHOCYTE CULTURE SUPERNATANTS AND GAMMA INTERFERON INCREASE BOTH CLASS I AND CLASS II HLA ANTIGENS , 1986, Transplantation.

[15]  J. Jeekel,et al.  RECOMBINANT LEUCOCYTE INTERFERON A INDUCES STEROID-RESISTANT ACUTE VASCULAR REJECTION EPISODES IN RENAL TRANSPLANT RECIPIENTS , 1984, The Lancet.

[16]  S. Pestka,et al.  Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. , 1982, Cellular immunology.

[17]  L. Harvey,et al.  Transferral of malignancy as a complication of organ transplantation: an insuperable problem? , 1981, Journal of clinical pathology.

[18]  P. Sweny,et al.  MALIGNANT MELANOMA IN PATIENT WITH RENAL TRANSPLANT , 1980, The Lancet.

[19]  R. Fairman,et al.  INADVERTENT TRANSPLANTATION OF A MELANOMA , 1980, Transplantation.

[20]  M. Peters,et al.  Metastatic malignant melanoma transplanted via a renal homograft. A case report , 1978, Cancer.

[21]  M. Seller SCREENING FOR NEURAL-TUBE DEFECTS , 1975, The Lancet.

[22]  Glasg Mb,et al.  Martha Graham Robson. , 1975 .

[23]  R. Farnsworth,et al.  Transplantation of malignant melanoma with cadaver kidney. , 1972, Transplantation.

[24]  C. Zukoski,et al.  Transplanted carcinoma in an immunosuppressed patient. , 1970, Transplantation.

[25]  R. Wilson,et al.  Immunologic rejection of human cancer transplanted with a renal allograft. , 1968, The New England journal of medicine.

[26]  M. Rubini,et al.  CADAVERIC RENAL HOMOTRANSPLANTATION WITH INADVERTENT TRANSPLANTATION OF CARCINOMA. , 1965, JAMA.